Orient Pharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	535.33	84.5	83.32	76.43	130.92	49.58
Short-Term Investments	9.8	24.8	29.8	20.8	20.8	140.8
Cash & Short-Term Investments	545.13	109.3	113.12	97.23	151.72	190.38
Cash Growth	-	-3.38%	16.34%	-35.92%	-20.30%	227.64%
Accounts Receivable	240.8	278.18	179.31	69.39	63.09	78.2
Other Receivables	10.06	10.36	8.16	12.91	16.82	2.35
Receivables	250.86	288.54	187.47	82.3	79.9	80.56
Inventory	352.22	279.56	233.97	194.18	156.88	138.64
Prepaid Expenses	26.13	44.12	58	39.18	30.91	14.75
Other Current Assets	9.51	6.91	29.7	10.24	19.89	9.5
Total Current Assets	1,184	728.43	622.25	423.12	439.31	433.83
Property, Plant & Equipment	850.08	891.83	944.96	903.28	769.71	792.66
Long-Term Investments	14.68	13.65	1.88	3.05	1.75	3.13
Other Intangible Assets	425.62	471.83	532.66	11.9	13.75	25.36
Long-Term Deferred Tax Assets	372.11	397.98	451.46	452.04	439.2	428.01
Other Long-Term Assets	40.77	16.87	9.47	54.18	100.1	60.82
Total Assets	2,887	2,521	2,563	1,848	1,764	1,744
Accounts Payable	69.15	36.14	55.57	61.97	19.6	28.63
Accrued Expenses	65.2	69.82	62.04	53.5	59.07	115.75
Short-Term Debt	-	250	314.5	68.5	161.5	32
Current Portion of Long-Term Debt	-	40	60.71	24.08	23.83	23.47
Current Portion of Leases	16.88	18.44	17.95	14.92	8.22	3.35
Current Unearned Revenue	63.4	64.51	22.01	64.87	78.07	44.73
Other Current Liabilities	7.69	8.35	30.56	63.22	69.17	2.33
Total Current Liabilities	222.31	487.25	563.35	351.06	419.46	250.25
Long-Term Debt	-	42.1	112.06	178.79	111.8	152.62
Long-Term Leases	183.7	195.95	211.67	221.86	109.67	112.26
Pension & Post-Retirement Benefits	5.98	5.86	5.09	5.94	6.85	9.67
Long-Term Deferred Tax Liabilities	1.57	1.84	-	-	0.13	0.01
Other Long-Term Liabilities	-	-	-	-	-	1.6
Total Liabilities	413.56	733	892.18	757.65	647.9	526.41
Common Stock	2,430	2,230	2,230	1,870	1,870	1,870
Additional Paid-In Capital	369.05	1,130	1,130	932.15	932.15	932.23
Retained Earnings	-332.21	-1,579	-1,686	-1,709	-1,682	-1,581
Comprehensive Income & Other	6.35	6.05	-3.83	-2.89	-4.6	-3.63
Shareholders' Equity	2,474	1,788	1,670	1,090	1,116	1,217
Total Liabilities & Equity	2,887	2,521	2,563	1,848	1,764	1,744
Total Debt	200.57	546.49	716.9	508.15	415.01	323.7
Net Cash (Debt)	344.56	-437.19	-603.78	-410.92	-263.29	-133.32
Net Cash Per Share	1.53	-1.96	-2.71	-2.20	-1.41	-0.79
Filing Date Shares Outstanding	243.04	223.04	223.04	187	187	187.01
Total Common Shares Outstanding	243.04	223.04	223.04	187	187	187.01
Working Capital	961.53	241.18	58.9	72.07	19.86	183.58
Book Value Per Share	10.18	8.01	7.49	5.83	5.97	6.51
Tangible Book Value	2,048	1,316	1,138	1,078	1,102	1,192
Tangible Book Value Per Share	8.43	5.90	5.10	5.76	5.89	6.37
Buildings	796.44	794.16	786.78	744.9	682.91	682.83
Machinery	450.4	439.37	430.96	367.95	361.11	340.78

Source: S&P Global Market Intelligence. Standard template. Financial Sources.